Status:

COMPLETED

Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali

Lead Sponsor:

Tampere University

Collaborating Sponsors:

Center for Vaccine Development CVD-Mali, Bamako, Mali

University College London Hospitals

Conditions:

Mortality

Eligibility:

All Genders

29-364 years

Phase:

PHASE3

Brief Summary

The LAKANA trial will assess the impact on mortality and other health outcomes of quarterly and biannual azithromycin mass drug administration (MDA) when delivered to 1-11-month (29-364 days) old infa...

Detailed Description

Mass drug administration (MDA) of azithromycin has been shown to reduce under-5 mortality in some but not all sub-Saharan African settings. Because of the observed heterogeneity and possible effect mo...

Eligibility Criteria

Inclusion

  • On a cluster (village) level:
  • Location within Kayes, Kita, or Koulikoro region of Mali
  • Considered accessible and safe by the local health authorities and research team
  • Considered non-urban by the local health authorities and research team
  • Permission from community leadership
  • On a household level (for trial enrollment):
  • Location within a cluster that is included in the study
  • Verbal consent from a head of household or an adult authorized by her / him
  • On a child level (for receiving study medication):
  • Residence in a household enrolled in the trial
  • Age between 29 and 364 days
  • Verbal consent from at least one caregiver

Exclusion

  • On child level (for not receiving study medication):
  • Weight below 3.0 kg
  • Known allergy to macrolides, as judged by a caregiver report of the infant experiencing an adverse reaction after oral ingestion of medication, which was deemed likely to be a macrolide by the interviewing data collector.

Key Trial Info

Start Date :

October 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

149201 Patients enrolled

Trial Details

Trial ID

NCT04424511

Start Date

October 15 2020

End Date

December 31 2024

Last Update

May 21 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center for Vaccine Development CVD-Mali

Bamako, Mali, BP 251